Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Moodys
Medtronic
Johnson and Johnson
Colorcon

Last Updated: January 18, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Pyridoxamine

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the drug development status for Pyridoxamine?

Pyridoxamine is an investigational drug.

There have been 6 clinical trials for Pyridoxamine. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2014.

The most common disease conditions in clinical trials are Diabetic Nephropathies, Kidney Diseases, and Diabetes Mellitus, Type 2. The leading clinical trial sponsors are BioStratum, NephroGenex, Inc., and Medpace, Inc.

There is one US patent protecting this investigational drug and ten international patents.

Recent Clinical Trials for Pyridoxamine
TitleSponsorPhase
Advanced Glycation Endproducts and Bone Material Strength in T2D Treated With PyridoxamineColumbia UniversityN/A
Pyridorin in Diabetic NephropathyCollaborative Study Group (CSG)Phase 3
Pyridorin in Diabetic NephropathyMedpace, Inc.Phase 3

See all Pyridoxamine clinical trials

Clinical Trial Summary for Pyridoxamine

Top disease conditions for Pyridoxamine
Top clinical trial sponsors for Pyridoxamine

See all Pyridoxamine clinical trials

US Patents for Pyridoxamine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Pyridoxamine   Start Trial Lipid compositions comprising triacylglycerol with long-chain polyunsaturated fatty acids at the sn-2 position COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (Acton, AU) GRAINS RESEARCH AND DEVELOPMENT CORPORATION (Barton, AU) NUSEED PTY LTD. (Laverton North, AU)   Start Trial
Pyridoxamine   Start Trial Compounds useful for the treatment of metabolic disorders and synthesis of the same North Carolina Central University (Durham, NC) The University of North Carolina at Chapel Hill (Chapel Hill, NC)   Start Trial
Pyridoxamine   Start Trial Particle detecting device AZBIL CORPORATION (Chiyoda-ku, JP)   Start Trial
Pyridoxamine   Start Trial Compositions and methods useful for ameliorating age related maladies NestecSA (Vevey, CH)   Start Trial
Pyridoxamine   Start Trial Nutritional composition for promoting gut microbiota balance and health Nestec S.A. (Vevey, CH)   Start Trial
Pyridoxamine   Start Trial Fused heterocyclic compound Takeda Pharmaceutical Company Limited (Osaka, JP)   Start Trial
Pyridoxamine   Start Trial Heterocyclic compound Takeda Pharmaceutical Company Limited (Tokyo, JP)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Pyridoxamine

Drugname Country Document Number Estimated Expiration Related US Patent
Pyridoxamine Argentina 098831 2033-12-18   Start Trial
Pyridoxamine Australia 2014366839 2033-12-18   Start Trial
Pyridoxamine Australia 2015281791 2033-12-18   Start Trial
Pyridoxamine Brazil 112016014508 2033-12-18   Start Trial
Pyridoxamine Brazil 112016030705 2033-12-18   Start Trial
Pyridoxamine Canada 2933909 2033-12-18   Start Trial
Pyridoxamine Canada 2953008 2033-12-18   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
Dow
Harvard Business School
Merck
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.